Covid-19 test and vaccine, conceptual illustration
Numéro d’image : 13198891
| Covid-19 test and vaccine, conceptual illustration. SARS-CoV-2 (previously 2019-nCoV) was first identified in Wuhan, China, in December 2019. It is an enveloped RNA (ribonucleic acid) virus. The coronaviruses take their name from their crown (corona) of surface proteins, which are used to attach and penetrate their host cells. Covid-19 is a respiratory infection that can lead to fatal pneumonia. As of 26 March 2020, over 500, 000 have been infected worldwide with over 20, 000 deaths. Travel restrictions and quarantines have been put in place to slow the spread of the virus. Research is ongoing into a vaccine for the SARS-CoV-2 coronavirus, but it is not expected to be available before 2021. | |
| Licence : | Libre de droits |
| Crédit: | Science Photo Library / Ktsdesign |
| Model Release : | Non requis |
| Property Release : | Non requis |
| Restrictions : | - |
Prix pour cette image À partir de 29 €
Pour une utilisation numérique (72 dpi)
À partir de 29 €
Pour un usage d'impression (300 dpi)
À partir de 325 €
Mots clés
- 2019 ncovid,
- 2019-cov,
- 2019-ncovid,
- aucun,
- biologie,
- biologique,
- concept,
- concepts,
- conceptuel,
- corona virus,
- coronavirus,
- coronavirus du syndrome respiratoire aigu sévère,
- covid 19,
- covid-19,
- covid19,
- dans le monde entier,
- désordre,
- entier,
- épidémie,
- épidémique,
- essai,
- état,
- global,
- hcov,
- illustration,
- immunisation,
- kit d'essai,
- maladie,
- micro-organisme,
- microbe,
- microbiologie,
- microbiologique,
- mondial,
- oeuvre,
- pandémie,
- pandémique,
- particule,
- pathogène,
- personne,
- résultat positif,
- sars,
- SARS coronavirus,
- SARS Cov 2,
- seringue,
- SRAS,
- structure,
- syndrome respiratoire aigu sévère,
- Syndrome respiratoire aigu sévère lié au coronavirus,
- test,
- texte,
- traitement,
- trouble,
- vaccin,
- vaccination,
- viral,
- virion,
- virologie,
- virus,
- virus d'ARN